Informed Prostate Cancer Patient Support

PSMA-bearing extracellular vesicles secreted from prostate cancer convert the microenvironment to a tumor-supporting, pro-angiogenic state. | bioRxiv

Neighborhood deprivation and risk of mortality among men with prostate cancer: Findings from a long‐term follow‐up study - K. C. - - The Prostate - Wiley Online Library

MRI Far Safer Than CT for Guiding Radiotherapy in Prostate Cancer

Getting Rid of Meat in Your Diet May Lower Cancer Risk | Cooking with Kathy Man

Alternative Approach Uses Sound Waves to Treat Prostate Cancer

A 'Cup of Tea' for the Prostate Improves Urine Flow : Water vapor ablation therapy was found to improve urination complaints even in men with "enormous" prostate glands.

Vegetarians have 14% lower cancer risk than meat-eaters, study finds | Vegetarianism | The Guardian

Real-world utilization and outcomes of docetaxel among older men with metastatic prostate cancer: a retrospective population-based cohort study in Canada | Prostate Cancer and Prostatic Diseases

Effects of cycling and rowing on serum concentrations of prostate‐specific antigen: A randomized study of 101 male subjects - Lunacek - - The Prostate - Wiley Online Library

Artificial intelligence trained with integration of multiparametric MR‐US imaging data and fusion biopsy trajectory‐proven pathology data for 3D prediction of prostate cancer: A proof‐of‐concept study - Kaneko - - The Prostate - Wiley Online Library

Genetic Score Predicts Lifetime Risk of Prostate Cancer Death

Non‐organ confined stage and upgrading rates in exclusive PSA high‐risk prostate cancer patients - Hoeh - - The Prostate - Wiley Online Library

Real-world patient characteristics associated with survival of 2 years or more after radium-223 treatment for metastatic castration-resistant prostate cancer (EPIX study) | Prostate Cancer and Prostatic Diseases

Allosteric interactions prime androgen receptor dimerization and activation | bioRxiv

PARP Inhibitors: Improving Outcomes in Metastatic Prostate Cancer

Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer | NEJM

Two PARP Inhibitors Impress as First-Line Add-Ons in mCRPC | MedPage Today

Three-drug combination prolongs survival in men with metastatic, hormone-sensitive prostate cancer -- ScienceDaily

Enzalutamide Rechallenge Yields Small PFS Boost in Metastatic Prostate Cancer | MedPage Today

Adding Darolutamide: New SOC for Metastatic Prostate Cancer

More evidence that physical activity is beneficial for prostate cancer | Prostate Cancer and Prostatic Diseases

Bayer: Darolutamide Significantly Increased Overall Survival in Patients with Metastatic Hormone-Sensitive Prostate Cancer in Phase 3 ARASENS Trial

Darolutamide Improves OS in Metastatic Prostate Cancer | MedPage Today

Top 10 Major Problems Of Low Testosterone In Men - YouTube

'I lost my dad to prostate cancer, don't lose yours' - BBC News

A 'living' cancer drug helps patients stay disease-free | Popular Science

Combination of MRI prostate and 18F‐DCFPyl PSMA PET/CT detects all clinically significant prostate cancers in treatment‐naive patients: An international multicentre retrospective study - Parathithasan - - Journal of Medical Imaging and Radiation Oncology - Wiley Online Library

AstraZeneca, Merck Report Lynparza Plus Abiraterone Improves Survival in 1st-Line Metastatic Castration-Resistant Prostate Cancer Patients

Virtual patient ‘surrogates’ can personalize cancer treatments: Mathematical models used as patient surrogates could help clinicians select the best cancer treatment before going to the patient’s bedside -- ScienceDaily

Salvage radiotherapy following HiFU: An institutional series and literature review - Mesci - - Journal of Medical Imaging and Radiation Oncology - Wiley Online Library

Watch S.S. Piers Sellers Cygnus Capsule Launch to the Space Station – Official NASA Broadcast - YouTube

Biden can easily cut the price prostate cancer drug Xtandi — Quartz

Keto diet may enhance chemotherapy for prostate cancer

The OncoLoop network-based precision oncology framework | bioRxiv

Advanced MRI could help to differentiate aggressive and slower growing prostate cancer

Exercise in advanced prostate cancer elevates myokine levels and suppresses in-vitro cell growth | Prostate Cancer and Prostatic Diseases : Altering the systemic milieu through exercise has been proposed as a potential mechanism underlying exercise-driven tumour suppression. It is not yet known whether men with advanced prostate cancer can elicit such adaptations following a program of exercise. The purpose is to examine myokine levels of serum acquired from metastatic castrate-resistant prostate cancer (mCRPC) patients recruited to the INTERVAL-GAP4 trial before and after 6 months of exercise and its tumour-suppressive effect. Twenty-five men with mCRPC (age = 74.7 ± 7.1 yrs) were randomised to supervised multimodal (aerobic and resistance) exercise (EX) or self-directed exercise control group (CON). Body composition was assessed using dual-energy x-ray absorptiometry (DXA), and fasting blood in a rested state was collected at baseline and at 6 months. Serum levels of myokines (SPARC,

Active Cellular Immunotherapy Disappoints in Metastatic Prostate Cancer | MedPage Today : In combination with chemotherapy, no OS benefit seen with DCVAC/PCa over placebo

Outcomes in men with metastatic castration-resistant prostate cancer who received sipuleucel-T and no immediate subsequent therapy: experience at Dana Farber and in the PROCEED Registry | Prostate Cancer and Prostatic Diseases

An AI-assisted Tool For Efficient Prostate Cancer Diagnosis | bioRxiv

Diving into our role in 50 top cancer drugs

Advanced prostate cancer antibody drug shows success in pet dogs -- ScienceDaily

Local versus systemic treatment intensification: what is the optimal strategy for localized prostate cancer? | Prostate Cancer and Prostatic Diseases

Widely-used hormone drug associated with increased risk of benign brain tumor at high doses -- ScienceDaily

United States Senate Committee on Veterans' Affairs

Urge Your Senator: Support a Clinical Pathway at the VA | ZERO - The End of Prostate Cancer

AUA Promotes H.R. 4880 and S. 2720, the Veterans’ Prostate Cancer Treatment and Research Act; AUA Advocacy Adds Senator Blackburn to List of Supporters

S.2720 - 117th Congress (2021-2022): Veterans’ Prostate Cancer Treatment and Research Act | Congress.gov | Library of Congress

Veterans Prostate Cancer Awareness – Make Blue the New Pink

Biden Aims To Reduce Cancer Deaths By 50% Over Next 25 Years (VIDEO)

Awaiting the perfect diagnostic test: optimal prostate cancer care begins without a diagnosis | Prostate Cancer and Prostatic Diseases

Kidney Doses in 177Lu-Based Radioligand Therapy in Prostate Cancer: Is Dose Estimation Based on Reduced Dosimetry Measurements Feasible? | Journal of Nuclear Medicine

Modified female mid‐urethral sling for the treatment of incontinence after prostate treatment: One‐center experience - Mao - - The Prostate - Wiley Online Library

Development of a nomogram combining multiparametric magnetic resonance imaging and PSA‐related parameters to enhance the detection of clinically significant cancer across different region - Zhou - - The Prostate - Wiley Online Library

Brachytherapy Boost May Allow for Shorter ADT With EBRT

Military Pilots’ DNA May Hold Key to What’s Causing Their Prostate Cancers - Defense One